SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-19-002554
Filing Date
2019-10-15
Accepted
2019-10-15 17:00:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d00322acl_10072019.htm SC 13D 91247
2 JOINT FILING AGREEMENT ex991to13d00322acl_10072019.htm EX-99.1 4465
  Complete submission text file 0000921895-19-002554.txt   96931
Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Filed by) CIK: 0001321178 (see all company filings)

Type: SC 13D

Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89137 | Film No.: 191151464
SIC: 2834 Pharmaceutical Preparations